StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
USNA

USANA Health Sciences, Inc.

USNA NYSE Medicinal Chemicals & Botanical Products EDGAR ↗
$17.37
-5.41 -23.75%

Key statistics

from XBRL data in SEC filings
Market cap
$321M
Revenue (TTM)
$926M
Net income (TTM)
$8.87M
EPS (TTM)
$0.50
P/E ratio
34.7
Dividend yield
Free cash flow
$8.53M
Cash
$163M
Total assets
$739M
Gross margin
77.6%
52-week range
$16.60 – $32.32

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release); Regulation FD disclosure Aug 4, 2026 8-K Shareholder vote results May 20, 2026 10-Q Quarter ended 2026-04-04 May 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 5, 2026 10-K Fiscal year ended 2026-01-03 Mar 16, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 18, 2026 8-K/A Director or officer change Feb 11, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Director or officer change; Regulation FD disclosure Jan 8, 2026 10-Q Quarter ended 2025-09-27 Nov 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 22, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 9, 2025 10-Q Quarter ended 2025-06-28 Aug 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 22, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jul 1, 2025 8-K Director or officer change; Shareholder vote results; Other events May 20, 2025 10-Q Quarter ended 2025-03-29 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 22, 2025 10-K Fiscal year ended 2024-12-28 Mar 12, 2025 8-K/A Mar 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 25, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Dec 23, 2024 10-Q Quarter ended 2024-09-28 Nov 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 22, 2024 10-Q Quarter ended 2024-06-29 Aug 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 23, 2024 8-K Shareholder vote results May 7, 2024 10-Q Quarter ended 2024-03-30 May 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2024 10-K Fiscal year ended 2023-12-30 Feb 27, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 6, 2024 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Oct 24, 2023 10-Q Quarter ended 2023-07-01 Aug 8, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Jul 25, 2023 8-K/A Director or officer change May 12, 2023 8-K Shareholder vote results May 11, 2023 10-Q Quarter ended 2023-04-01 May 9, 2023 8-K Regulation FD disclosure; Other events May 4, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Apr 25, 2023